A disease-associated mutation in a transporter protein impairs gut barrier function, leading to gastrointestinal disease and chronic infections.

The Medical Scientist Training Program has been intentional in approaching the challenges presented by COVID-19.

The NCI program project grant is supporting multiple projects that aim to define fundamental biological principles about extracellular RNA signaling and the development and aggressiveness of colorectal cancer, the second leading cause of cancer death in the United States.

Sophie Katz, MD, MPH, is one of four early career infectious diseases physicians in the United States to receive the award, which provides $100,000 of funding support from the Centers for Disease Control and Prevention.

“I’m so happy to be helping make VUMC safer.”

New insights on influenza genome packaging could guide strategies for interfering with the virus’s life cycle and ability to cause infection.